Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Lung Lai

Showing results (41-50 of 288) with videos related to

Pageof 29
Sort By:
World Journal of Gastroenterology|March 20, 2008
Natural history of hepatitis-related hepatocellular carcinomaDavid-Yiu-Kuen But, Ching-Lung Lai, Man-Fung Yuen
Lancet (London, England)|December 31, 2003
Viral hepatitis CThierry Poynard, Man-Fung Yuen, Vlad Ratziu, et al.
Lancet (London, England)|December 31, 2003
Viral hepatitis BChing Lung Lai, Vlad Ratziu, Man-Fung Yuen, et al.
Hepatology International|June 23, 2011
The use of transient elastography in the management of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Expert Opinion on Emerging Drugs|March 5, 2016
Emerging drugs for the treatment of hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|June 21, 2011
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfectionWai-Kay Seto, Man-Fung Yuen, James Fung, et al.
Journal of Clinical Gastroenterology|August 24, 2012
Future prevention and treatment of chronic hepatitis B infectionWai-Kay Seto, James Fung, Man-Fung Yuen, et al.
Journal of Gastroenterology and Hepatology|December 31, 2013
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatmentJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Hepatology|October 7, 2004
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)Man-Fung Yuen, Philip Ip, Wai-Kuen Ng, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Pageof 29

Showing results (41-50 of 288) with videos related to

Sort By:
Pageof 29
World Journal of Gastroenterology|March 20, 2008
Natural history of hepatitis-related hepatocellular carcinomaDavid-Yiu-Kuen But, Ching-Lung Lai, Man-Fung Yuen
Lancet (London, England)|December 31, 2003
Viral hepatitis CThierry Poynard, Man-Fung Yuen, Vlad Ratziu, et al.
Lancet (London, England)|December 31, 2003
Viral hepatitis BChing Lung Lai, Vlad Ratziu, Man-Fung Yuen, et al.
Hepatology International|June 23, 2011
The use of transient elastography in the management of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Expert Opinion on Emerging Drugs|March 5, 2016
Emerging drugs for the treatment of hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|June 21, 2011
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfectionWai-Kay Seto, Man-Fung Yuen, James Fung, et al.
Journal of Clinical Gastroenterology|August 24, 2012
Future prevention and treatment of chronic hepatitis B infectionWai-Kay Seto, James Fung, Man-Fung Yuen, et al.
Journal of Gastroenterology and Hepatology|December 31, 2013
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatmentJames Fung, Wai-Kay Seto, Ching-Lung Lai, et al.
Journal of Hepatology|October 7, 2004
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)Man-Fung Yuen, Philip Ip, Wai-Kuen Ng, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Pageof 29